Brian DeSchuytner
2019
In 2019, Brian DeSchuytner earned a total compensation of $895.6K as Senior Vice President, Finance & Product Strategy at Mersana Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $78,432 |
|---|---|
| Option Awards | $637,128 |
| Salary | $180,013 |
| Total | $895,573 |
DeSchuytner received $637.1K in option awards, accounting for 71% of the total pay in 2019.
DeSchuytner also received $78.4K in non-equity incentive plan and $180K in salary.
Rankings
In 2019, Brian DeSchuytner's compensation ranked 9,777th out of 13,971 executives tracked by ExecPay. In other words, DeSchuytner earned more than 30.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,777 out of 13,971 | 30th |
Division Manufacturing | 3,939 out of 5,695 | 31st |
Major group Chemicals And Allied Products | 1,499 out of 2,194 | 32nd |
Industry group Drugs | 1,282 out of 1,880 | 32nd |
Industry Pharmaceutical Preparations | 950 out of 1,392 | 32nd |
Source: SEC filing on April 20, 2020.
DeSchuytner's colleagues
We found four more compensation records of executives who worked with Brian DeSchuytner at Mersana Therapeutics in 2019.
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020